化妆品填充剂市场：按产品类型、材料类型、应用、地区 - 规模、份额、展望、机会分析2022-2028

美容填充剂近年来迅速普及，因为它们提供以前只能通过手术才能实现的年轻化和美学改善。真皮填充剂、唇部和麵部填充剂、皱纹填充剂或软组织填充剂均已获得 FDA 批准，可打造更光滑、更饱满的面部外观。由于消费者对美容的关注度越来越高，对外观的兴趣也越来越大，注射美容的需求量逐年增加。

市场动态。

化妆品填充剂需求的增长、对面部美学的日益关注、整容手术数量的增加以及老年人口的增加是预计在预测期内推动全球化妆品填充剂市场增长的主要因素。

2022 年 8 月，艾伯维旗下公司 Allergan Aesthetics 获得美国食品和药物管理局 (FDA) 的批准，宣布 JUVEDERM VOLUX XC 用于改善 21 岁及以上成年人的中度至重度下巴减少。

2022 年 2 月，Merz Aesthetics 进行深层注射（皮下和/或骨膜上）软组织填充，以改善 21 岁及以上成年人中度至重度下颌轮廓缺失，宣布推出 Radiesse(+) 利多卡因注射植入物。

这项研究的主要特点

• 本报告对化妆品填料市场进行了深入分析，提供了以 2021 年为基准年的预测期 (2022-2028) 的市场规模和復合年增长率 (CAGR%)。
• 它还揭示了各个细分市场的潜在收入机会，并描述了一个有吸引力的市场投资建议矩阵。
• 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
• 公司简介根据以下参数展示了全球化妆品填料市场的领先企业，包括公司亮点、产品组合、主要亮点、业绩和战略。
• 参与这项研究的主要公司包括 Teoxane Laboratories、Suneva Medical Inc.、Sinclair Pharma、Merz Pharma、Vital Esthetique、Galderma Pharma SA、Laboratories Vivacy SAS 和 Allergan PLC (Abbvie Inc.) 等。
• 这份报告中的见解将使营销人员和企业高管能够就他们未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。将是
• 本报告针对行业中的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球化妆品填料市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第二章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 按产品类型划分的市场概况
  • 按材料类型分类的市场概况
  • 市场概况：按应用分类
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 整形手术的增加
  • 与美容填充剂相关的副作用
  • 全球对面部美容的需求增加
• 影响分析
• 主要亮点
• 监管情景
• 产品发布和批准
• 害虫分析
• 对 PORTER 的分析
• 合併/收购场景

第 4 章全球化妆品填料市场-冠状病毒 (COVID-19) 大流行的影响

• COVID-19 的流行病学
• 供应方和需求方分析
• 经济影响

第 5 章全球化妆品填料市场：按产品类型，2017-2028

• 吸收性
• 不可吸收

第 6 章全球化妆品填料市场：按材料类型分类，2017-2028

• 聚合物和颗粒
• 胶原蛋白
• 透明质酸

第 7 章：全球化妆品填料市场，按应用，2017-2028

• 面部线条矫正和皱纹
• 整容
• 唇部护理
• 其他用途

第 8 章全球化妆品填料市场，按地区划分，2017-2028

• 北美
• 欧洲
• 亚太地区
• 拉丁美洲
• 中东和非洲
• 世界其他地方

第9章竞争格局

• Teoxane Laboratories
• Suneva Medical Inc.
• Sinclair Pharma
• Merz Pharma
• Laboratories Vivacy SAS
• Vital Esthetique
• Galderma Pharma SA
• Allergan PLC（Abbvie Inc.）

第 10 章

• 调查方法介绍
• 关于出版商

The popularity of aesthetic fillers has grown rapidly in recent years as they provide rejuvenating and enhancing aesthetic improvements that previously could only be achieved with surgery. Dermal fillers, lip and facial fillers, wrinkle fillers, or soft tissue fillers are approved by FDA to create a smoother and/or fuller appearance in the face. The demand for aesthetic injectable has increased over the years as a result of customers' increasing emphasis on beauty or increase in focus on the physical appearance.

Market Dynamics:

Increasing demand for aesthetics fillers, increase in attention on facial aesthetics, rise in number of cosmetic procedures, and growing geriatric population are major factors expected to propel the growth of the global aesthetic fillers market over the forecast period.

In August 2022, Allergan Aesthetics, an AbbVie company announced the U.S. Food and Drug Administration (FDA) approval of JUVEDERM VOLUX XC for the improvement of jawline definition in adults over the age of 21 with moderate to a severe loss of jawline definition.

In February 2022, Merz Aesthetics announced the launch of Radiesse (+) Lidocaine injectable implant for deep injection (subdermal and/or supraperiosteal) for soft tissue augmentation to improve moderate to a severe loss of jawline contour in adults over the age of 21.

Key features of the study:

• This report provides in-depth analysis of the aesthetic fillers market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global aesthetic fillers market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Teoxane Laboratories, Suneva Medical Inc., Sinclair Pharma, Merz Pharma, Vital Esthetique, Galderma Pharma SA, Laboratories Vivacy SAS, and Allergan PLC (Abbvie Inc.), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global aesthetic fillers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aesthetic fillers market.

Detailed Segmentation:

• Global Aesthetic Fillers Market, By Product Type:
  • Absorbable
  • Non-absorbable
• Global Aesthetic Fillers Market, By Material Type:
  • Polymers and Particles
  • Collagen
  • Hyaluronic Acid
• Global Aesthetic Fillers Market, By Application:
  • Facial Line Correction and Wrinkles
  • Face Lift
  • Lip Treatment
  • Other Applications
• Global Aesthetic Fillers Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Teoxane Laboratories
  • Suneva Medical Inc.
  • Sinclair Pharma
  • Merz Pharma
  • Laboratories Vivacy SAS
  • Vital Esthetique
  • Galderma Pharma SA
  • Allergan PLC (Abbvie Inc.)

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Material Type
  • Market Snapshot, By Application
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increase in the number of cosmetic procedures
  • Side effects associated with aesthetic fillers
  • Increasing demand for facial aesthetics worldwide
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Aesthetic Fillers Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Aesthetic Fillers Market, By Product Type, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Absorbable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Non-absorbable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Aesthetic Fillers Market, By Material Type, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Polymers and Particles
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Collagen
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Hyaluronic Acid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Aesthetic Fillers Market, By Application, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Facial Line Correction and Wrinkles
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Face Lift
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Lip Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Global Aesthetic Fillers Market, By Geography, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

9. Competitive Landscape

• Teoxane Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Suneva Medical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sinclair Pharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merz Pharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Laboratories Vivacy SAS
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Vital Esthetique
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Galderma Pharma SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Allergan PLC (Abbvie Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us